The recent performance of John Wiley & Sons presents a puzzle for investors. While the academic publishing giant reported quarterly earnings that surpassed expectations and subsequently boosted its share repurchase plan, its stock has experienced notable downward pressure. This analysis delves into the financial results, strategic actions, and the market’s seemingly contradictory response.
Financial Performance: A Mixed Bag with Clear Highlights
For its second quarter of fiscal 2026, ended October 31, John Wiley & Sons posted revenue of $421.75 million. This figure represents a slight decrease from the $426.6 million reported in the prior-year period but exceeded the consensus estimate of $416.4 million. More impressively, the company’s bottom-line performance showed marked improvement.
Net income reached $44.89 million, with reported earnings per share (EPS) of $1.10, comfortably beating the $0.97 analyst consensus. Operational efficiency was a key driver, as the company achieved a 250-basis-point expansion in its adjusted operating margin. Management attributed this improvement to rigorous cost control, ongoing technology transformation, and productivity initiatives powered by artificial intelligence.
A breakdown by segment reveals the source of both strength and weakness:
* Research Segment: Revenue grew 5% on a constant currency basis, fueled by a 25% surge in open-access article output and significant AI licensing revenue, which totaled $4.8 million for the quarter.
* Learning Segment: This division faced headwinds, recording an 11% decline in revenue, which acted as a drag on the company’s overall top-line result.
Despite the mixed segment performance, the corporate outlook remains unchanged, with Wiley reaffirming its full-year guidance.
Should investors sell immediately? Or is it worth buying John Wiley, Sons?
Strategic Moves and Market Sentiment
In a clear signal of confidence and a commitment to returning capital to shareholders, Wiley’s board recently increased its share repurchase allocation for fiscal 2026 to $100 million. This authorization is part of a broader $250 million buyback program. CEO Matthew Kissner highlighted the sustained demand in the Research business and pointed to the growing utilization of Wiley’s content in large language models and corporate AI applications as a promising growth vector.
However, these fundamentally positive developments have not been mirrored in the share price. Following the earnings announcement and buyback news, the stock recently closed a session with a loss of approximately 2.7%. Over a ten-day period, it declined nearly 12%. This downturn occurs even as some analysts have issued more bullish ratings on the equity.
The Path Forward
The market’s caution appears to stem from a combination of short-term technical factors and persistent concerns over the softness in the Learning segment. The critical question for investors is whether the robust momentum in Research and the emerging revenue stream from AI licenses can fully offset the challenges in the education business.
The next significant data point will be the release of Q3 fiscal 2026 results, anticipated around March 5, 2026. This report will provide crucial evidence on the sustainability of the current growth drivers. Ultimately, the success of the expanded buyback program in fostering a lasting recovery in the share price may hinge on those upcoming figures demonstrating that the company’s strategic pivot is yielding the intended financial results.
Ad
John Wiley, Sons Stock: Buy or Sell?! New John Wiley, Sons Analysis from December 13 delivers the answer:
The latest John Wiley, Sons figures speak for themselves: Urgent action needed for John Wiley, Sons investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from December 13.
John Wiley, Sons: Buy or sell? Read more here...
